Tompkins Financial Corp Purchases New Shares in Henry Schein, Inc. (NASDAQ:HSIC)

Tompkins Financial Corp bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,670 shares of the company’s stock, valued at approximately $429,000.

A number of other institutional investors have also recently made changes to their positions in HSIC. Xponance Inc. increased its position in Henry Schein by 2.1% during the third quarter. Xponance Inc. now owns 21,839 shares of the company’s stock valued at $1,622,000 after acquiring an additional 443 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in Henry Schein in the 3rd quarter worth about $348,000. Bessemer Group Inc. lifted its stake in Henry Schein by 26.0% in the second quarter. Bessemer Group Inc. now owns 6,437 shares of the company’s stock worth $522,000 after purchasing an additional 1,328 shares during the last quarter. Caxton Associates LP boosted its position in shares of Henry Schein by 80.8% during the third quarter. Caxton Associates LP now owns 18,991 shares of the company’s stock valued at $1,410,000 after buying an additional 8,486 shares during the period. Finally, Adage Capital Partners GP L.L.C. bought a new position in shares of Henry Schein during the third quarter valued at approximately $16,650,000. Institutional investors own 93.31% of the company’s stock.

Analysts Set New Price Targets

HSIC has been the subject of a number of recent analyst reports. StockNews.com cut Henry Schein from a “buy” rating to a “hold” rating in a report on Monday, December 4th. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. SVB Leerink assumed coverage on shares of Henry Schein in a report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. TheStreet upgraded shares of Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. Finally, Barrington Research lifted their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of “Hold” and an average price target of $81.09.

Get Our Latest Analysis on HSIC

Henry Schein Trading Up 0.3 %

HSIC opened at $74.58 on Friday. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The firm has a market cap of $9.58 billion, a price-to-earnings ratio of 23.68, a PEG ratio of 1.87 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $85.75. The stock has a fifty day moving average price of $75.19 and a 200-day moving average price of $72.77.

Henry Schein (NASDAQ:HSICGet Free Report) last announced its earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The firm had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the prior year, the firm posted $1.21 earnings per share. The business’s revenue for the quarter was down 10.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Insider Activity at Henry Schein

In other news, CEO Stanley M. Bergman sold 13,962 shares of the firm’s stock in a transaction on Tuesday, December 26th. The stock was sold at an average price of $75.14, for a total value of $1,049,104.68. Following the completion of the sale, the chief executive officer now owns 168,633 shares of the company’s stock, valued at approximately $12,671,083.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 11,238 shares of the company’s stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $74.02, for a total transaction of $831,836.76. Following the transaction, the chief executive officer now owns 57,831 shares in the company, valued at approximately $4,280,650.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Stanley M. Bergman sold 13,962 shares of the firm’s stock in a transaction on Tuesday, December 26th. The stock was sold at an average price of $75.14, for a total transaction of $1,049,104.68. Following the completion of the transaction, the chief executive officer now directly owns 168,633 shares of the company’s stock, valued at approximately $12,671,083.62. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.